AFP and hepatocellular carcinoma: Wang et al. examined the miRNA profile of EVs derived from HCC and cirrhotic patients and found that certain upregulated miRNAs (miR-122, miR-148a, and miR-1246) outperformered AFP in distinguishing HCC from cirrhosis.